Recherche
-
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
(HemaSphere. vol. 4, n° 3, pp. e364, 2020-06)Article de revueLibre accès -
Monitoring changes in the cellular content of biomolecules during ageing with FTIR spectroscopy
(Vibrational Spectroscopy. vol. 105, pp. 102972, 2019-11)Article de revue -
A combined approach for the early recognition of acute kidney injury after adult cardiac surgery
(Anaesthesia Critical Care & Pain Medicine. vol. 37, n° 4, pp. 335–341, 2018-08)Article de revue -
Complete remission of immune thrombocytopenia in a 30‐year old woman after excision of a right atrial myxoma
(British Journal of Haematology. pp. 16135, 2019-08)Article de revueAccès réservé -
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP)
(Haemophilia. vol. 25, n° 5, pp. 731–737, 2019-09)Article de revue -
In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia
(Molecular Genetics & Genomic Medicine. vol. 6, n° 2, pp. 249–260, 2018-03)Article de revueLibre accès -
Na+/H+ Exchanger Isoform 1-Induced Osteopontin Expression Facilitates Cardiomyocyte Hypertrophy
(PLoS ONE. vol. 10, n° 4, pp. e0123318, 2015-04)Article de revueLibre accès -
A plea for renin-angiotensin system blockers as first-line treatment in cases of severe acute hypertension.
(Nephrology Dialysis Transplantation, 2020-12-25)Article de revueLibre accès -
Are biological functions selected effects ? Justin Garson: What biological functions are and why they matter
(Metascience. vol. 29, n° 1, pp. 107–111, 2020-04-16)Article de revue -
État actuel de l’utilisation en essais cliniques de molécules radiomarquées au 68Ga en France. Exemple du site de Bordeaux
(Médecine Nucléaire. vol. 42(6), pp. 428–431, 2018)Article de revue